Vicarious Surgical Inc.
Description
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.
About
CEO
Mr. Adam David Sachs
Employees
129
Instrument type
Common Stock
Sector
Healthcare
Industry
Medical Devices
MIC code
XNYS
Address
78 Fourth Avenue, Waltham, MA 02451, United States
×
![Enlarged Chart]()
Oscillators
No data available
Summary
No data available
Moving Averages
No data available
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 10, 2025 | — | — | — | — |
| Aug 11, 2025 | — | — | — | — |
| Apr 28, 2025 | — | — | — | — |
| Mar 3, 2025 | — | — | — | — |
| Nov 13, 2024 | -2.56 | -2.90 | -0.34 | 13.28% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 2 | — | 3 |
| Average estimate | — | -3.16 | — | -9.53 |
| Low estimate | — | -3.45 | — | -11.58 |
| High estimate | — | -2.87 | — | -7.08 |
| Last year EPS | — | -2.70 | — | -11.02 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-28.100%
Next qtr. (Mar 2025)
-17.040%
Current year
29.360%
Next year (Dec 2025)
13.550%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total reported revenue | — | — | — | — |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 47.58M | 43.90M | 22.06M | 9.80M |
| Selling general and admin | 33.09M | 36.18M | 16.16M | 3.19M |
| Other operating expenses | — | — | — | — |
| Operating income | -80.67M | -80.08M | -38.22M | -12.99M |
| Non operating interest income | ||||
| Income | 4.43M | 1.44M | 20,000 | 113,000 |
| Expense | 25,000 | 200,000 | 89,000 | 3,000 |
| Other income expense | 5.19M | 84.00M | 3.09M | — |
| Pretax income | -71.07M | 5.16M | -35.21M | -12.88M |
| Tax provision | — | — | — | — |
| Net income | -71.07M | 5.16M | -35.21M | -12.88M |
| Basic EPS | -14.70 | 1.20 | -1.80 | -3.26 |
| Diluted EPS | -14.70 | 1.20 | -1.80 | -3.26 |
| Basic average shares | 4.87M | 4.06M | 4.04M | 3.95M |
| Diluted average shares | 4.87M | 4.06M | 4.04M | 3.95M |
| EBITDA | -74.38M | -77.53M | -37.89M | -12.72M |
| Net income from continuing op. | -71.07M | 5.16M | -35.21M | -12.88M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Total assets | 119.86M | 140.29M | 181.68M | 17.79M |
| Current assets | ||||
| Cash | — | — | — | — |
| Cash equivalents | — | — | — | — |
| Cash and cash equivalents | 52.82M | 116.21M | 173.51M | 16.87M |
| Other short term investments | 45.36M | — | — | — |
| Accounts receivable | — | — | — | — |
| Other receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Prepaid assets | — | — | 4.87M | 258,000 |
| Restricted cash | — | — | — | — |
| Assets held for sale | — | — | — | — |
| Hedging assets | — | — | — | — |
| Other current assets | 2.78M | 4.20M | 4.87M | 258,000 |
| Non current assets | ||||
| Properties | 11.46M | 12.27M | — | — |
| Land and improvements | — | — | — | — |
| Machinery furniture equipment | 5.66M | 4.12M | 1.40M | 705,000 |
| Construction in progress | — | — | — | — |
| Leases | 4.29M | 4.16M | 1.43M | 24,000 |
| Accumulated depreciation | -3.55M | -1.70M | -584,000 | -284,000 |
| Goodwill | — | — | — | — |
| Investment properties | — | — | — | — |
| Financial assets | — | — | — | — |
| Intangible assets | — | — | — | — |
| Investments and advances | — | — | — | — |
| Other non current assets | 1.05M | 1.03M | 1.06M | 218,000 |
| Total liabilities | 21.90M | 29.25M | 98.59M | 935,000 |
| Current liabilities | ||||
| Accounts payable | 1.26M | 1.73M | 1.50M | 373,000 |
| Accrued expenses | 912,000 | 568,000 | 865,000 | 103,000 |
| Short term debt | 1.05M | 854,000 | 647,000 | 47,000 |
| Deferred revenue | — | — | — | — |
| Tax payable | — | — | — | — |
| Pensions | 4.06M | 5.24M | 3.23M | 291,000 |
| Other current liabilities | — | — | — | — |
| Non current liabilities | ||||
| Long term debt | 13.79M | 14.83M | 691,000 | 63,000 |
| Provision for risks and charges | — | — | — | — |
| Deferred liabilities | — | — | — | — |
| Derivative product liabilities | 830,000 | 6.02M | 90.02M | — |
| Other non current liabilities | — | — | — | — |
| Shareholders equity | ||||
| Common stock | 17,000 | 13,000 | 12,000 | 9,000 |
| Retained earnings | -132.71M | -61.64M | -66.80M | -31.59M |
| Other shareholders equity | 10,000 | — | — | — |
| Total shareholders equity | 97.97M | 111.05M | 83.09M | 16.85M |
| Additional paid in capital | 230.65M | 172.67M | 149.88M | 48.44M |
| Treasury stock | — | — | — | — |
| Minority interest | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Net Income | -71.07M | 5.16M | -35.21M | -12.88M |
| Depreciation | 1.85M | 1.11M | 316,000 | 157,000 |
| Deferred Taxes | — | — | — | — |
| Stock-Based Compensation | 13.27M | 12.26M | 3.69M | 448,000 |
| Other Non-Cash Items | -418,000 | 904,000 | 21,000 | — |
| Accounts Receivable | — | — | — | — |
| Accounts Payable | -473,000 | 135,000 | 1.13M | 170,000 |
| Other Assets & Liabilities | -860,000 | 845,000 | 733,000 | -15,000 |
| Operating Cash Flow | -57.70M | 20.41M | -29.32M | -12.12M |
| Investing Activities | ||||
| Capital Expenditures | -1.67M | -5.35M | -1.29M | -120,000 |
| Net Intangibles | — | — | — | — |
| Net Acquisitions | — | — | — | — |
| Purchase of Investments | -75.70M | — | — | — |
| Sale of Investments | 31.59M | — | — | 13.32M |
| Investing Cash Flow | -45.78M | -5.35M | -1.29M | 13.20M |
| Financing Activities | ||||
| Long-Term Debt Issuance | — | — | 1.50M | — |
| Long-Term Debt Payments | -16,000 | -1.40M | -197,000 | -48,000 |
| Other Financing Charges | -2.82M | -300,000 | 190.42M | — |
| Financing Cash Flow | 44.41M | 8.30M | 191.73M | 13.47M |
| Other Cash Details | ||||
| End Cash Position | 53.76M | 117.14M | 174.56M | 16.99M |
| Income Tax Paid | — | — | — | — |
| Interest Paid | 1,000 | 41,000 | 36,000 | 3,000 |
| Free Cash Flow | -63.98M | -66.56M | -34.59M | -12.16M |
Top Institutional Holders
| Holder | Date Reported | Shares | Value | % Held |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | Sep 30, 2024 | 95,077 | 1.25M | 1.81% |
| Vanguard Extended Market Index Fund | Sep 30, 2024 | 32,755 | 431,710 | 0.62% |
| Fidelity Extended Market Index Fund | Nov 30, 2024 | 17,310 | 228,145 | 0.33% |
| Bridgeway Funds Inc-Ultra Small Company Fund | Sep 30, 2024 | 11,800 | 155,524 | 0.22% |
| Fidelity Total Market Index Fund | Nov 30, 2024 | 5,680 | 74,862 | 0.11% |
| Fidelity Series Total Market Index Fund | Nov 30, 2024 | 4,098 | 54,011 | 0.08% |
| Vanguard Balanced Index Fund | Sep 30, 2024 | 2,122 | 27,967 | 0.04% |
| ProShares Tr-Ultra Russell 2000 ProShares Fd | Nov 30, 2024 | 1 | 13 | 0.00% |
Article
Vicarious Surgical Announces Departure of Chief Financial Officer
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the pending departure of William Kelly, its Chief Financial Officer (CFO), to pursue other career opportunities, after nearly four years of dedicated service with the Company. Mr. Kelly has served as Vicarious Surgical's CFO since January 2021. He will assist.
Dec 6, 2024
Article
Vicarious Surgical Inc. (RBOT) Q3 2024 Earnings Call Transcript
Vicarious Surgical Inc. (NYSE:RBOT ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Kaitlyn Brosco – Director-Investor Relations Adam Sachs – Co-Founder and Chief Executive Officer Bill Kelly – Chief Financial Officer Conference Call Participants Adam Maeder – Piper Sandler Operator Hello, everyone, and welcome to Vicarious Surgical's Third Quarter 2024 Earnings Call. My name is Lydia and I'll be your operator today.
Nov 13, 2024
Article
Vicarious Surgical Reports Third Quarter 2024 Financial Results
WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the quarter ended September 30, 2024. Management will host a corresponding conference call at 4:30 p.m. ET today, November 12, 2024. “Our team's strong execution throughout the year, continuing in the third quarter, has us on track to ac.
Nov 12, 2024
